Wendy Recant
- Oncology top 5%
- Molecular Biology top 10%
- Cancer Research top 5%
- Surgery top 5%
- Pathology and Forensic Medicine top 2%
- Co-authors
- Everett E. VokesKerstin StensonEzra E.W. CohenWalter M. StadlerDezheng HuoFred RosenRalph R. WeichselbaumRosemarie Mick
- Topics
- Breast Lesions and Carcinomas (10 papers)Breast Cancer Treatment Studies (9 papers)Cancer-related Molecular Pathways (4 papers)
- Partner nations
- United StatesCyprus
In The Last Decade
Wendy Recant
46 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 101
- Oncology 972
- Molecular Biology 764
- Cancer Research 559
- Surgery 539
- Pathology and Forensic Medicine 502
Countries citing papers authored by Wendy Recant
This map shows the geographic impact of Wendy Recant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Recant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Recant more than expected).
Fields of papers citing papers by Wendy Recant
This network shows the impact of papers produced by Wendy Recant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Recant. The network helps show where Wendy Recant may publish in the future.
Co-authorship network of co-authors of Wendy Recant
This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Recant. A scholar is included among the top collaborators of Wendy Recant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Recant. Wendy Recant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 53 | |
| 2 | 41 | |
| 3 | 41 | |
| 4 | 31 | |
| 5 | 18 | |
| 6 | 2 | |
| 7 | 6 | |
| 8 | 2 | |
| 9 | 71 | |
| 10 | 14 | |
| 11 | 1 | |
| 12 | 143 | |
| 13 | Human breast cancer susceptibility to paclitaxel therapy is independent of Bcl-2 expression. | 15 |
| 14 | 64 | |
| 15 | 22 | |
| 16 | 119 | |
| 17 | 91 | |
| 18 | 23 | |
| 19 | 16 | |
| 20 | 17 |
About Wendy Recant
Wendy Recant is a scholar working on Pathology and Forensic Medicine, Cancer Research and Oncology, having authored 47 papers that have together received 2.4k indexed citations. Recurring topics across this work include Breast Lesions and Carcinomas (10 papers), Breast Cancer Treatment Studies (9 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Otorhinolaryngology (391 citations), Cancer Research (559 citations) and Oncology (972 citations). Wendy Recant has collaborated with scholars based in United States and Cyprus. Frequent co-authors include Everett E. Vokes, Kerstin Stenson, Ezra E.W. Cohen, Walter M. Stadler, Dezheng Huo, Fred Rosen, Ralph R. Weichselbaum, Rosemarie Mick, Ruth Heimann and Carol A. Westbrook. Their work appears in journals such as JAMA, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.